Advance Auto Parts IncQ2 results showed headline EPS inflated by one-time tariff refunds, revealing weak underlying performance.
U.S. stock futures were little changed on Thursday as investors assessed a fresh batch of corporate earnings and analyst actions. CrowdStrike shares fell 2.8% in premarket trading after Bloomberg reported that the cybersecurity company's chief technology officer is departing to launch an artificial intelligence-focused cybersecurity fund. Advance Auto Parts stock plunged 15.9% after its second-quarter results revealed a significant difference between headline earnings and underlying performance, with about $0.31 of the reported $1.03 adjusted diluted earnings per share coming from one-time tariff refunds. Deere shares jumped 5.1% after the agricultural and construction equipment maker delivered a stronger-than-expected fiscal third quarter, with diluted earnings per share of $5.10 and net sales of about $11 billion. Etsy gained 3.9% in premarket trading after BofA Securities upgraded the online marketplace to Buy from Neutral and raised its price target to $105 from $88. Ultragenyx surged 11.1% after the U.S. Food and Drug Administration granted accelerated approval to GENGLYCOS, also known as DTX401, a gene therapy for glycogen storage disease type Ia in patients aged eight and older. Moderna shares fell 13% in premarket trading, retreating after more than doubling in the previous session following the company's major cancer-vaccine trial announcement with Merck. Wolfspeed plunged 10.5% after the semiconductor company reported a sharply wider-than-expected fiscal fourth-quarter loss, with an adjusted loss of $2.26 per share and revenue of $149.6 million. Webull rose 13.8% after the digital brokerage reported its strongest quarterly results since going public, with second-quarter revenue of $198.8 million and adjusted earnings of $0.05 per share.
Advance Auto Parts IncQ2 results showed headline EPS inflated by one-time tariff refunds, revealing weak underlying performance.
Etsy, Inc.Upgraded to Buy from Neutral with price target raised to $105 from $88.
UltragenyxUltragenyx surged 11.1% after the FDA granted accelerated approval to GENGLYCOS, a gene therapy for glycogen storage disease type Ia.
Moderna IncModerna shares fell 13% in premarket trading, retreating after more than doubling in the previous session following the company's major cancer-vaccine trial announcement with Merck.
Webull CorpStrongest quarterly results since going public with revenue and adjusted EPS beating expectations.
Deere & CompanyStronger-than-expected fiscal Q3 with EPS of $5.10 and net sales of $11 billion.
Wolfspeed, Inc.Wolfspeed plunged 10.5% after reporting a sharply wider-than-expected fiscal fourth-quarter loss, with an adjusted loss of $2.26 per share and revenue of $149.6 million.
Crowdstrike Holdings IncCTO departure to launch AI-focused fund reported, causing premarket decline.